Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Define the principles of impact in Medical Affairs and consider the role of metrics and KPIs in impact assessment.
Explore approaches to impact in different settings: the industry (biotech to big pharma), disease states (rare to more prevalent), and therapeutic technologies (e.g., gene therapy and wearables).
Generate insights on the practical adoption of impact in Medical Affairs’ strategic and tactical approaches.
Consider the importance and role of Medical Affairs as a key driver of impact and its role within the cross-functional team.
 This session examines how integrating behavioral science insights (how humans make decisions and what drives their behavior) and adult education best practices (how adults best acquire, retain, and use knowledge) can evolve external medical education from knowledge dissemination alone to behavioral understanding and, ultimately, impactful outcomes.
Key discussion points will include:Â
1) Why Behavioral Science Matters in Medical Education: Explore the limitations of knowledge-based education and the importance of driving behavioral change for impactful outcomes.
2) Essential Behavioral Science Concepts for Medical Education: Identify and discuss key behavioral science principles that can enhance educational effectiveness.
3) Practical Integration of Behavioral Science into Medical Education: Provide strategies for incorporating behavioral science into educational activities, including real-world examples and practical guidance on how to address common challenges.
This resource is intended to provide Medical Affairs teams the rationale for meaningful ​value and impact measurements, as well as tips to support these:​
The objective of this White Paper is to guide Medical Affairs personnel on the key components of the legal, regulatory, and industry codes of practice requirements which are applicable to Medical Affairs in Pharma and Medical Devices industries, and how to identify and mitigate risks. This paper also includes company control frameworks for compliance with the requirements through policies, processes (usually captured in Standard Operating Procedures [SOPs]), systems, training, monitoring, and audit.
In this webinar, we will discuss how to develop a customer-centric engagement strategy leveraging an omnichannel approach. We will take a step-by-step look at how to:
· Integrate medical and CX strategy
· Leverage data to fuel audience segmentation and targeting
· Build a scientific customer journey
· Create tailored content using an effective content strategy
· Prioritize and deploy a relevant channel mix
· Optimize your approach through measurement, reporting, and insight generation
This webinar is appropriate for companies along the spectrum of omnichannel maturity. Â We will discuss how to leverage a crawl-walk-run approach, taking the next best step wherever you are.
This S&G is intended to provide a common understanding of the framework in which External Education, led by Medical Affairs, ultimately benefits patients. The intent is to provide guidance and recommendations to Medical Affairs professionals and offer practical tools for planning, executing, and evaluating external education activities and funding determinations.
This Standard and Guidance is intended to inform learners about the Evidence Generation function, strategic direction, and operations across multiple geographies.
Regulatory bodies such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasingly recognising the value of supplementing clinical trial data with real-world evidence to improve understanding of drug performance in the healthcare setting.
Consequently, Pharma companies are increasingly including real-world studies in their evidence to:
• Understand the opportunities and best practices for involving patient partners in the generation of real-world evidence
• Explore, using case studies, the value of patient engagement in the design, delivery, analysis and communication of real-world studies
• Highlight the importance of Medical Affairs and Health Economics and Outcomes Research (HEOR) professionals in partnering with colleagues from different functions in Pharma to ensure patients are effectively engaged throughout the product lifecycle
• Discuss barriers and propose solutions to optimal patient engagement in real-world studies
This webinar, hosted by the MAPS APAC Chapter, aims to provide a comprehensive and practical overview of how Artificial Intelligence (AI) can be integrated into various functions of Medical Affairs. Attendees will gain insights into the application of AI in medical strategy, note-taking during advisory boards, setting agendas, and enhancing scientific communication. By the end of the session, participants will have a clear understanding of the tools and techniques available, and how to implement them effectively to improve efficiency and outcomes in their roles.
In this webinar, we will share new data showing that while medical affairs is increasing in importance, it is still struggling to reach a consensus around medical impact metrics. However, measuring medical impact is no longer a choice; it’s a necessity for medical to communicate its value as a business function and better demonstrate its contributions to successful patient outcomes.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.